Home » EMA Adopts Risk-Based Policy for Scientists’ Conflict of Interest
EMA Adopts Risk-Based Policy for Scientists’ Conflict of Interest
November 17, 2010
The European Medicines Agency (EMA) will assign a risk level to potential conflicts of interest for outside scientific experts and use this to restrict their activities with the agency as needed, according to an updated policy on handling conflicts of interest. Includes the full text of European Medicines Agency Policy on Conflicts of Interest.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor